Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2520-1026
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results ; volume:5 ; number:1 ; day:20 ; month:9 ; year:2021 ; pages:1-11 ; date:12.2021
BMC Rheumatology ; 5, Heft 1 (20.9.2021), 1-11, 12.2021
- Creator
-
Deodhar, Atul A.
Mease, Philip J.
Rahman, Proton
Navarro-Compán, Victoria
Strand, Vibeke
Hunter, Theresa
Bolce, Rebecca
Leon, Luis
Lauzon, Steve
Marzo-Ortega, Helena
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41927-021-00205-3
- URN
-
urn:nbn:de:101:1-2021100519204148619447
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Deodhar, Atul A.
- Mease, Philip J.
- Rahman, Proton
- Navarro-Compán, Victoria
- Strand, Vibeke
- Hunter, Theresa
- Bolce, Rebecca
- Leon, Luis
- Lauzon, Steve
- Marzo-Ortega, Helena
- SpringerLink (Online service)
Other Objects (12)
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis
Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks
Ixekizumab (axiale Spondyloarthritis) : Addendum zum Auftrag A20-66
Ixekizumab (axiale Spondyloarthritis) : Nutzenbewertung gemäß § 35a SGB V
Ixekizumab bei Psoriasis-Arthritis & axialer Spondyloarthritis : umfassende Daten zu Ixekizumab: schnelle und kontinuierliche Wirksamkeit
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis
Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks
Ixekizumab (axiale Spondyloarthritis) : Addendum zum Auftrag A20-66
Ixekizumab (axiale Spondyloarthritis) : Nutzenbewertung gemäß § 35a SGB V
Ixekizumab bei Psoriasis-Arthritis & axialer Spondyloarthritis : umfassende Daten zu Ixekizumab: schnelle und kontinuierliche Wirksamkeit
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis
Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks
Ixekizumab (axiale Spondyloarthritis) : Addendum zum Auftrag A20-66
Ixekizumab (axiale Spondyloarthritis) : Nutzenbewertung gemäß § 35a SGB V
Ixekizumab bei Psoriasis-Arthritis & axialer Spondyloarthritis : umfassende Daten zu Ixekizumab: schnelle und kontinuierliche Wirksamkeit
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements